<div><strong>MISSION:</strong> The Jordan Avi Ogman Foundation’s mission is to save our 9 year old son Jordan’s life, who was diagnosed with TECPR2, a fatal, neurodegenerative, debilitating, genetic disease.
</div>
<div><br />
</div>
<div><strong>Website:</strong> <em>SavingJordan.org</em>
</div>
<div><br />
</div>
<div><strong>CBS News: </strong>TV Interview of David &amp; Stacey Ogman (Parents of Jordan): <a href="https://cbs12.com/news/local/4-year-old-battles-rare-debilitating-disease-parents-pin-hopes-on-new-treatment" target="_blank" rel="noreferrer noopener">CBS News</a>
</div>
<div><br />
</div>
<div><strong>Dr Oz's Tweet for Jordan:</strong><a href="https://mobile.twitter.com/droz/status/1217921075931119617?fbclid=IwAR1mJ5gy5mn6moAi5nc2a9clCFErYEh9t1ZFP8VF_jFjVeOaUatlR5-Mo1w" target="_blank" rel="noreferrer noopener"><a href="https://mobile.twitter.com/droz/status/1217921075931119617?fbclid=IwAR1mJ5gy5mn6moAi5nc2a9clCFErYEh9t1ZFP8VF_jFjVeOaUatlR5-Mo1w" target="_blank" class="" rel="nofollow noopener noreferrer">https://mobile.twitter.com/droz/status/1217921075931119617?fbclid=IwAR1mJ5gy5mn6moAi5nc2a9clCFErYEh9t1ZFP8VF_jFjVeOaUatlR5-Mo1w</a></a> 
</div>
<div><br />
</div>
<div>Saving the lives of Jordan and the other children with TECPR2 can potentially lead to breakthroughs for other neurodegenerative diseases of the brain. TECPR2 and many well-known neurodegenerative diseases of the brain—such as ALS, Parkinson’s disease, and Alzheimer’s—are all suspected to share a commonality of failure, impairment and/ or abnormalities of the autophagy process. It is excruciatingly painful to know that there is an autophagy impairment occurring in our sweet 9 year old son's brain/ central nervous system. 
</div>
<div><br />
</div>
<div><strong>JORDAN'S JOURNEY:</strong> Jordan was born in Boca Raton, Florida, on July 20, 2015. Pregnancy was pretty blissful but we encountered difficulties hours after his birth. Despite being born at term, Jordan stayed seven nights in the NICU, clearing fluid from his lungs and showing us what a fighter he is. Aside from fighting off a few serious respiratory infections, Jordan’s first year was filled with lots of baby giggles and sheer joy as we watched him hit all milestones. 
</div>
<div><br />
</div>
<div>After Jordan’s first birthday, he didn’t continue hitting the usual milestones. While he never regressed, we found ourselves cheering on inchstones, not milestones. We sought early intervention services, including physical therapy, occupational therapy, developmental and speech therapy. Jordan continued to make small gains, albeit at a much slower pace than this peers and without the same strength and ease that our daughter, Jordan’s older sister, progressed with. Despite doctors and therapists assuring us that every child develops at their own rate, as Jordan neared his second birthday, we knew in our hearts that Jordan’s developmental delay was not of benign origin, and that he would not catch up one day.
</div>
<div><br />
</div>
<div>Thus we started down the path of trying to find the underlying cause of his delays. We consulted our pediatrician, a developmental pediatrician, several neurologists, an endocrinologist—the list of specialists goes on and on. Jordan underwent an MRI, EEG, microarray analysis, metabolic and other blood work, and specific genetic testing, all of which came back relatively normal. We so badly wanted to breathe a sigh of relief when the microarray analysis came back with the words “normal male chromosome,” but we knew our medical/special needs journey wasn’t over. Finally, we sought out a neurogeneticist, who agreed to run a whole exome sequence test. The test targets exons, which are the protein-coding regions of the human genome. 
</div>
<div><br />
</div>
<div><strong>DIAGNOSIS DAY and ACTION:</strong> After waiting months for results of the whole exome sequencing DNA test, Diagnosis Day arrived. On September 17, 2019, at the age of 4 years old, Jordan was diagnosed with a rare and fatal neurodegenerative disease of the brain: TECPR2. 
</div>
<div><br />
</div>
<div>Immediately, after Diagnosis Day, we reached out to neurogeneticists and neurologists across the world seeking help and guidance. We then flew to Boston to confirm the diagnosis and to meet with a series of neurogeneticists, neurobiologists, and critical care physicians. We are not doctors, we are special needs parents, and what we have learned is nearly too excruciating to bear. Our son is dying and there is no available treatment or cure at this time for TECPR2. We were told to enjoy our time with our son and brace ourselves for decisions that will need to be made in the very near future, such as when to place him on a ventilator. 
</div>
<div><br />
</div>
<div>In the weeks after his diagnosis, despite feeling devastated and powerless, we took comfort in Jordan himself, and in the power of neuroplasticity: the brain’s ability to change and overcome that which is inborn. Cheerful and hardworking as ever, in addition to his daily therapies, Jordan completed two intensive therapy courses, in an effort to keep his body as strong as it can be to maintain his quality of life.
</div>
<div><br />
</div>
<div>We have also been able to find comfort and strength in meeting and speaking with the very few other amazing and wonderful TECPR2 families that we know of who are devoted to finding a treatment/ cure for TECPR2. Their support and efforts towards finding a treatment/ cure has become a lifeline for us and we are ever so grateful. 
</div>
<div><br />
</div>
<div><strong>PROGRESSION OF THE DISEASE:</strong> Jordan rises to the occasion, time and time again, fighting every second of every day, for his ability to swallow, walk without falling, and articulate his thoughts and needs with his extremely limited ability to speak. TECPR2 has already robbed him of so much, including, but not limited to, cognitive ability and his ability to maintain balance and coordinate movements, both physical and verbal, leading to falling multiple times an hour and frustration due to speech delay. Despite the daily challenges Jordan faces from TECPR2, his smile and laugh continue to light up any room he enters. He is loving, kind, playful and beyond determined. We are special needs parents not doctors trying our best to understand our son's disease. Doctors have described that in the near future, without a treatment/cure, TECPR2 progressive degeneration will rob Jordan of his winning personality and of any ability to walk, say words, meaningfully interact, and get enough oxygen while sleeping or awake leading to a rapid decline and premature death.
</div>
<div><br />
</div>
<div><strong>THE QUEST FOR THE CURE: THERE IS HOPE!</strong> We are beyond grateful for the partnership of our university scientists who are determined to find a treatment/cure for Jordan. We are not doctors, we are special needs parents, but we have learned that therapeutics and gene therapy is a logical and natural progression of the last 20 years of research in medical genetics and molecular biology. As this information has accumulated, it has become clear that virtually every disease has a genetic component. Thus, if the right gene is delivered to the right location in the body at the right time, there is a potential for significant improvements in the management and correction of many human diseases. Because essentially similar strategies can be applied to an extremely broad range of human diseases, the potential of gene therapy is considered to be extraordinary. It is our family's hope and firm belief that TECPR2 will be the next genetic disease amenable to therapeutics and gene therapy. 
</div>
<div><br />
</div>
<div><strong>GOAL:</strong> The goal of the Jordan Avi Ogman Foundation is to raise awareness and funds for a treatment and cure for TECPR2, a rare and fatal disease. Jordan is a rare disease warrior who is determined, resilient, bright and just the sweetest and funniest little boy. We can’t and won’t lose him to TECPR2. 
</div>
<div><br />
</div>
<div><strong>CALL TO ACTION:</strong> We need your help to raise $5 million dollars immediately to have our academic labs complete their research and pursue the plan of action for a treatment/cure. 
</div>
<div><br />
</div>
<div><strong>THE TIMELINE:</strong> This is a true race against the clock. This is a fatal disease so the time is now to join us in saving Jordan's life.
</div>
<div><br />
</div>
<div><strong>CBS News: </strong>State House of Representatives Presents Jordan With a Tribute in His Battle Against TECPR2 disease: <a href="https://cbs12.com/news/local/lawmaker-recognizes-boca-raton-couple-fighting-to-save-their-4-year-old-son" target="_blank" rel="noreferrer noopener"><strong><a href="https://cbs12.com/news/local/lawmaker-recognizes-boca-raton-couple-fighting-to-save-their-4-year-old-son" target="_blank" class="" rel="nofollow noopener noreferrer">https://cbs12.com/news/local/lawmaker-recognizes-boca-raton-couple-fighting-to-save-their-4-year-old-son</a></strong></a>
</div>
<div><br />
</div>
<div><strong>CBS News: </strong>Fundraising Dinner TV Interview:<a href="https://cbs12.com/news/local/fundraising-dinner-held-for-4-year-old-battling-rare-fatal-brain-disease" target="_blank" rel="noreferrer noopener"><strong><a href="https://cbs12.com/news/local/fundraising-dinner-held-for-4-year-old-battling-rare-fatal-brain-disease" target="_blank" class="" rel="nofollow noopener noreferrer">https://cbs12.com/news/local/fundraising-dinner-held-for-4-year-old-battling-rare-fatal-brain-disease</a></strong></a><strong> </strong>
</div>
<div><br />
</div>
<div><strong>CBS News: </strong>U.S. Congressman Ted Deutch Meets Jordan:<a href="https://cbs12.com/news/local/rep-deutch-visits-4-year-old-battling-rare-fatal-disease-promotes-research-funding" target="_blank" rel="noreferrer noopener"><strong><a href="https://cbs12.com/news/local/rep-deutch-visits-4-year-old-battling-rare-fatal-disease-promotes-research-funding" target="_blank" class="" rel="nofollow noopener noreferrer">https://cbs12.com/news/local/rep-deutch-visits-4-year-old-battling-rare-fatal-disease-promotes-research-funding</a></strong></a>
</div>
<div><br />
</div>
<div><strong>NBC NEWS: </strong>4 Year Old Jordan Fights Brain Disease: <a href="https://www.wptv.com/news/region-s-palm-beach-county/boca-raton/boca-raton-4-year-old-fights-fatal-brain-disease" target="_blank" rel="noreferrer noopener"><a href="https://www.wptv.com/news/region-s-palm-beach-county/boca-raton/boca-raton-4-year-old-fights-fatal-brain-disease" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.wptv.com/news/region-s-palm-beach-county/boca-raton/boca-raton-4-year-old-fights-fatal-brain-disease</a></a>
</div>
<div><br />
</div>
<div><strong>Delray Beach Newspaper Story: </strong><a href="https://delraynewspaper.com/boca-raton-family-seeks-cure-for-rare-genetic-disease-to-save-4-year-old-son-29515" target="_blank" rel="noreferrer noopener"><strong><a href="https://delraynewspaper.com/boca-raton-family-seeks-cure-for-rare-genetic-disease-to-save-4-year-old-son-29515" target="_blank" class="" rel="nofollow noopener noreferrer">https://delraynewspaper.com/boca-raton-family-seeks-cure-for-rare-genetic-disease-to-save-4-year-old-son-29515</a></strong></a>
</div>
<div><br />
</div>
<div><strong>Miami Dolphins Quarterback Jay Fiedler (Video Supporting Jordan): </strong><a href="https://www.youtube.com/watch?v=74iQC9nF0w8" target="_blank" rel="noreferrer noopener"><strong><a href="https://www.youtube.com/watch?v=74iQC9nF0w8" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.youtube.com/watch?v=74iQC9nF0w8</a></strong></a>
</div>
<div><br />
</div>
<div><strong>CONTACT:</strong><a href="https://gmail.com" target="_blank" rel="noreferrer noopener">[email redacted]</a>
</div>
<div><br />
</div>
<div>#TECPR2
</div>
<div><br />
</div>
<div>*Right to Indemnification. Each person (including here and hereinafter, the heirs, executors, administrators, or estate of such person) (1) who is or was a director or trustee of the Corporation, (2) who is or was an officer, agent or employee of the Corporation and as to whom the Corporation has agreed to grant such indemnity hereunder, or (3) who is or was serving at the request of the Corporation as its representative in the position of a director, officer, trustee, partner, agent, or employee of another corporation, partnership, joint venture, trust or other enterprise and as to whom the Corporation has agreed to grant such indemnity hereunder, shall be indemnified by the Corporation as of right to the fullest extent permitted or authorized by current or future legislation or by current or future judicial or administrative decision (but, in the case of any future legislation or decision, only to the extent that it permits the Corporation to provide broader indemnification rights than permitted prior to the legislation or decision), against all fines, liabilities, settlements, losses, damages, costs and expenses, including attorneys' fees, asserted against him or incurred by him in his capacity as such director, officer, trustee, partner, agent, employee or representative, or arising out of his status as such director, officer, trustee, partner, agent, employee or representative. The foregoing right of indemnification shall not be exclusive of other rights to which those seeking indemnification may be entitled. The Corporation may maintain insurance, at its expense, to protect itself and any such person against any such fine, liability, cost or expense, including attorney's fees, whether or not the Corporation would have the legal power to directly indemnify him against such liability.* *The Jordan Avi Ogman Foundation, Inc., is a Florida nonprofit corporation with 501(c)(3) status.*
</div>

Addison Goldin

Anonymous

Daniel Shulman

Arthur Mourjan

Jonathan Ahdoot

Alan Stander

Samson Silberman

Brian Krebs

Debra Burrell

Seth Kaminstein

Doug Grant

Gary Haftel

Risa Pulver

Rocky Kaller

Rich Cea

Jordan Avi Ogman Foundation

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

Eligible for Profile Share Badge

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

isEligibleForProfileBadge

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.3.0 and above

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Jordan Avi Ogman Foundation

Still $4,568,863 to go. Help us build momentum.